NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Fresh off record-breaking momentum across its game portfolio, Revolving Games is entering its next phase of growth driven by ...

Ather Energy announces the launch of its third R&D center, 'The Juggernaut', focusing on rapid product development and ...

FRONT-1 Phase 3 expected data readout accelerated from H2 2027 to H1 20274FRONT-2 Phase 3 trial initiated ahead of schedule Streamlined late-stage clinical and pre-commercial organization aligns with ...

Interim Phase 3 Results Support Ovaprene's Differentiation as a First-in-Category, Hormone-Free, Intravaginal Monthly ContraceptiveSAN DIEG ...

Küche7’s mission is to change residential spaces through the use of stainless steel and practical design. Its vision is to ...

Taiwan’s Compal Electronics has completed the initial phase (phase one) of its new manufacturing facility in Czeladź, Poland, ...

Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. | Rhythm Pharmaceuticals’ push to ...

In today's fast-paced digital world, delivering value swiftly without compromising quality is essential. Generative AI ( ...

Kapital Bank has successfully completed its “PO Growth” development program aimed at strengthening product-oriented thinking ...

In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the ...